Phase
Condition
Healthy Volunteers
Treatment
N/AClinical Study ID
Ages 18-100 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
A. Volunteer individuals
B. Lab Eligibility parameters (for contrast scans with in 4 weeks of gadolinium injection):
Creatinine below upper normal limit
eGFR greater than or equal to 60 mL/min/1.73m(2)
Age greater than or equal to 60 or history of renal disease: test GFR within 1week prior to contrast
C. Willing to travel to the NIH for follow-up visits.
D. Greater than or equal to 18 years old
E. Able to understand and sign informed consent
F. No MRI scan with gadolinium injection in the last 6 months under this protocol.
Exclusion
EXCLUSION CRITERIA:
A. Implanted metal clips or wires of the type which may concentrate radiofrequency fields or cause tissue damages from twisting in a Magnetic field. Examples:
Aneurysm clip, implanted neural stimulator,
Implanted cardiac pacemaker, defibrillator, or certain other implanted electrical ormetallic devices,
Cochlear implant, ocular foreign body (metal shavings),
Any implanted device (pumps, infusion devices, etc.),
Shrapnel injuries,
History of metal in head or eyes or other parts of the body.
B. Pregnant women
C. Paralyzed hemidiaphragm
D. Over 500 lbs and/or a body circumference that prevents the study subject from laying flat in the scanner
E. Surgery of uncertain type
F. Untreatable claustrophobia otherwise requiring anesthesia.
G. Any contraindications that the Physician identifies from the subject, MRI Safety Questionnaire, and/or History and Physical.
EXCLUSION FOR PARTICIPATION FOR GADOLINIUM CONTRAST:
(Inclusive of the above exclusion criteria):
A. Allergy to gadolinium for scans using contrast; will be eligible for non-contrast scans.
B. Acute renal failure, renal transplant, dialysis and renal failure individuals (eGFR <60 mL/min/1.73m(2) and/or clinically diagnosed).
C. Individuals with a history of liver transplant or severe liver disease.
D. Lactating women
E. Individuals with hemoglobinopathies or severe asthma.
F. Patient preference to not undergo intravenous line placement and/or receive gadolinium contrast. Contrast administration is optional and participants may still undergo a non-contrast study.
G. GBCA with an MRI scan in the last 6 months. This includes scan performed with GBCA at any outside institution and/or at the clinical center .In addition, they cannot have reached their maximum of 4 GBCA imaging studies under this protocol. They will be excluded from having a contrast enhanced MRI, but will not be excluded from the protocol for non-contrast MRI studies.
Study Design
Study Description
Connect with a study center
National Institutes of Health Clinical Center
Bethesda, Maryland 20892
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.